Trupanion price target raised to $62 from $52 at Piper Sandler

Piper Sandler analyst John Barnidge raised the firm’s price target on Trupanion (TRUP) to $62 from $52 and keeps an Overweight rating on the shares. The firm notes the company experienced higher than expected level of enrolled pets in Q1, which indicates strong product adoption. Trupanion is seeing positive traction across the vet channel, which should help support future growth in enrolled pets, Piper adds.